Xingfan Biotechnology Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Investors
  • 4

Xingfan Biotechnology General Information

Description

Provider of drug development services intended to create differentiated small-molecule drugs for oncology treatment. The company offers oncology drug development, small-molecule drug research, clinical trial translation services, pharmaceutical research collaboration, and project transaction services, enabling the pharmaceutical industry to address unmet medical needs through efficient research and clinical translation.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Unit O, 5th Floor
  • Number 780 Cailun Road, China Pilot Free Trade Zone
  • Shanghai, 201203
  • China
+86 189
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • Unit O, 5th Floor
  • Number 780 Cailun Road, China Pilot Free Trade Zone
  • Shanghai, 201203
  • China
+86 189

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Xingfan Biotechnology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 16-Apr-2026 Completed Generating Revenue
To view Xingfan Biotechnology’s complete valuation and funding history, request access »

Xingfan Biotechnology Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Guxin Capital Growth/Expansion Minority
IDG Capital Venture Capital Minority
Suzhou Oriza Holdings Corporation Asset Manager Minority
Teng Yuan Capital Venture Capital Minority
To view Xingfan Biotechnology’s complete investors history, request access »

Xingfan Biotechnology FAQs

  • When was Xingfan Biotechnology founded?

    Xingfan Biotechnology was founded in 2024.

  • Where is Xingfan Biotechnology headquartered?

    Xingfan Biotechnology is headquartered in Shanghai, China.

  • What industry is Xingfan Biotechnology in?

    Xingfan Biotechnology’s primary industry is Drug Discovery.

  • Is Xingfan Biotechnology a private or public company?

    Xingfan Biotechnology is a Private company.

  • What is Xingfan Biotechnology’s current revenue?

    The current revenue for Xingfan Biotechnology is .

  • Who are Xingfan Biotechnology’s investors?

    Guxin Capital, IDG Capital, Suzhou Oriza Holdings Corporation, and Teng Yuan Capital have invested in Xingfan Biotechnology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process